Abuse potential of mirogabalin in recreational polydrug users

• Hoofdauteurs: Jeanne Mendell (Auteur), Naama Levy-Cooperman (Auteur), Ed Sellers (Auteur), Bradley Vince (Auteur), Debra Kelsh (Auteur), James Lee (Auteur), Vance Warren (Auteur), Hamim Zahir (Auteur)
• Formaat: Boek
• Gepubliceerd in: SAGE Publishing, 2019-04-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Mirogabalin is a selective calcium channel α 2 δ subunit ligand being developed to treat neuropathic pain. In accordance with US Food and Drug Administration (FDA) guidance, the human abuse potential of mirogabalin (15-105 mg) was examined, relative to placebo, diazepam (15 or 30 mg), and pregabalin...